SCHEMBL16019986

SCHEMBL16019986

CCOC(=O)[C@@H](Cc1ncn(C(c2ccccc2)(c2ccccc2)c2ccccc2)n1)NC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.43
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
CTSS P25774 4/20 0.40
CTSK P43235 3/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
TACR1 P25103 2/20 0.39
ADORA1 P30542 2/20 0.39
ACE P12821 1/20 0.39
TP53 P04637 1/20 0.39
KLK5 Q9Y337 1/20 0.39
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16019963 1.00 SCN9A (0.43) SCN9AALDH1A1MAPTCYP1A2CYP2C9
SCHEMBL16019944 0.90 ACE (0.48) ALDH1A1CTSSCTSKCTSLCTSB
SCHEMBL16017457 0.86 TP53 (0.38) MAPTTP53TSHR
SCHEMBL16017454 0.76 MAPT (0.34) ALDH1A1MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL12122453 0.76 CTSS (0.64) SCN9ACYP1A2CYP2C9CYP2C19HTT
SCHEMBL1273042 0.76 CTSS (0.64) SCN9ACYP1A2CYP2C9CYP2C19HTT
SCHEMBL689021 0.72 LMNA (0.44) ALDH1A1MAPTTP53KDM4EHPGD
SCHEMBL11913040 0.72 SIRT2 (0.61) CTSSCTSKCTSLCTSBKLK5
SCHEMBL13810396 0.72 SIRT2 (0.61) CTSSCTSKCTSLCTSBKLK5
SCHEMBL5361692 0.71 SIRT2 (0.53) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256698-A1 CATHEPSIN INHIBITORS VIROBAY, INC. 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256698-A1 CATHEPSIN INHIBITORS CTSF, CTSZ, CTSV SCN9A 4508/4885ALDH1A1 3635/4885MAPT 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.